Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Development of vaccines for Marburg hemorrhagic fever
Daniel G. Bausch
,
Thomas W. Geisbert
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development of vaccines for Marburg hemorrhagic fever'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vaccine Development
100%
Marburg Hemorrhagic Fever
100%
Ebola Virus
100%
Fatality
50%
Hemorrhagic Fever
50%
Antiviral Drugs
50%
Nonhuman Primate Model
50%
High Mortality Rate
50%
Angola
50%
Recombinant Vesicular Stomatitis Virus
50%
Selling
50%
Central Africa
50%
Marburg
50%
Rainforest
50%
Ebola Outbreak
50%
Democratic Republic of Congo
50%
Popular Work
50%
Hot Zone
50%
Medicine and Dentistry
Ebolavirus
100%
Marburg Hemorrhagic Fever
100%
Mortality Rate
33%
Infection
33%
Case Fatality Rate
33%
Hemorrhagic Fever
33%
Vesiculovirus
33%
Antiviral Drug
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ebola Virus
100%
Marburg Virus Disease
100%
Infection
33%
Mortality Rate
33%
Antiviral Drug
33%
Hemorrhagic Fever
33%
Vesiculovirus
33%
Case Fatality Rate
33%
Immunology and Microbiology
Hemorrhagic Fever
100%
Ebola Virus
100%
Mortality Rate
33%
Case Fatality Rate
33%
Vesiculovirus
33%
Infection
33%